Arg399
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.2
Powered by Cell Signaling Technology
Home > Mono-methylation Site Page: > Arg399  -  FXR2 (mouse)

Site Information
FrPPGSGrGGsGGGs   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 7641400

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 )
Disease tissue studied:
testicular cancer ( 8 , 9 )
Relevant cell line - cell type - tissue:
'brain, embryonic' ( 14 ) , brain ( 1 , 2 , 3 , 13 ) , embryo ( 1 , 4 , 5 , 6 , 7 ) , F9 (testicular) ( 9 ) , heart ( 15 ) , kidney ( 10 , 11 ) , lung ( 12 ) , P19 (testicular) ( 8 )

References 

1

Guo A, et al. (2014) Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol Cell Proteomics 13, 372-87
24129315   Curated Info

2

Guo A (2013) CST Curation Set: 18332; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -;
Curated Info

3

Guo A (2013) CST Curation Set: 18337; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -;
Curated Info

4

Guo A (2013) CST Curation Set: 18343; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

5

Guo A (2013) CST Curation Set: 18345; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

6

Guo A (2013) CST Curation Set: 18346; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

7

Guo A (2013) CST Curation Set: 18347; Year: ; Biosample/Treatment: tissue, embryo/-; Disease: -; SILAC: -;
Curated Info

8

Zhou J (2010) CST Curation Set: 9114; Year: 2010; Biosample/Treatment: cell line, P19/untreated; Disease: testicular cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

9

Zhou J (2010) CST Curation Set: 9111; Year: 2010; Biosample/Treatment: cell line, F9/untreated; Disease: testicular cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

10

Zhou J (2009) CST Curation Set: 7948; Year: 2009; Biosample/Treatment: tissue, kidney/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

11

Zhou J (2009) CST Curation Set: 7947; Year: 2009; Biosample/Treatment: tissue, kidney/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

12

Zhou J (2009) CST Curation Set: 7945; Year: 2009; Biosample/Treatment: tissue, lung/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

13

Zhou J (2008) CST Curation Set: 3811; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

14

Zhou J (2008) CST Curation Set: 3812; Year: 2008; Biosample/Treatment: tissue, brain, embryonic/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info

15

Zhou J (2008) CST Curation Set: 3813; Year: 2008; Biosample/Treatment: tissue, heart/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R
Curated Info